{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:28:38Z","timestamp":1774366118558,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>To investigate the efficacy of an artificial intelligence (AI)-based fluid monitoring tool in optimizing the monitoring of neovascular age-related macular degeneration (nAMD) patients in a Brazilian cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a retrospective real-world study performed in a tertiary center in Brazil, including patients with nAMD. Spectral-domain optical coherence tomography (Spectralis, Heidelberg Engineering, Germany) images were processed at baseline and over 2 years of follow-up. Demographic and clinical data were collected. A deep learning algorithm (Fluid Monitor, RetInSight, Austria) was used to automatically quantify intraretinal fluid (IRF), subretinal fluid (SRF) and pigment epithelial detachment (PED). A longitudinal panel regression model and Log-Rank test were performed to assess the correlation between fluid volumes and treatment frequency, visual outcomes, macular atrophy (MA) and subretinal fibrosis (SF) development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Ninety-nine eyes from 84 patients were included. Fifty-eight eyes were treatment-na\u00efve. Higher IRF and PED in the 6\u00a0mm area were correlated with worse visual outcomes over a 2-year follow-up (<jats:italic>p<\/jats:italic>\u2009=\u20090.01 and <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, respectively). Higher IRF, SRF and PED were correlated with an increased risk of SF development (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, <jats:italic>p<\/jats:italic>\u2009=\u20090.049 and <jats:italic>p<\/jats:italic>\u2009=\u20090.02 respectively). MA development showed no significant correlation with higher IRF, SRF nor PED in this analysis. Higher SRF volume correlated with a greater number of required intravitreal injections over 2-years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study investigates the multifaceted landscape of nAMD in a tertiary center in the Southeast Brazil using an AI-based fluid monitoring tool. Further studies that highlight the significance of using newly validated technologies across diverse populations worldwide will be of interest.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40942-025-00695-0","type":"journal-article","created":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T17:08:12Z","timestamp":1751821692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Automated fluid monitoring to optimize the follow-up of neovascular age-related macular degeneration patients in the Brazilian population"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6127-6770","authenticated-orcid":false,"given":"Virginia","family":"Mares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7661-4015","authenticated-orcid":false,"given":"Gregor S.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniel","family":"Feitosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Gumpinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hrvoje","family":"Bogunovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7788-7311","authenticated-orcid":false,"given":"Ursula","family":"Schmidt-Erfurth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-0346","authenticated-orcid":false,"given":"Marcio B.","family":"Nehemy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,6]]},"reference":[{"key":"695_CR1","unstructured":"Progress M, Jager RD, Mieler WF, Miller JW. Age-Related Macular Degeneration. Published online 2008."},{"issue":"10153","key":"695_CR2","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","volume":"392","author":"P Mitchell","year":"2018","unstructured":"Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392(10153):1147\u201359. https:\/\/doi.org\/10.1016\/S0140-6736(18)31550-2.","journal-title":"Lancet"},{"key":"695_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, David M, Brown JS, Heier DS, Boyer PKK. Ranibizumab for neovascular Age-Related macular degeneration. N Engl J Med. 2006;355:11\u201320.","journal-title":"N Engl J Med"},{"issue":"8","key":"695_CR4","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/J.OPHTHA.2016.03.045","volume":"123","author":"MG Maguire","year":"2016","unstructured":"Maguire MG, Martin DF, Ying G, shuang, et al. Five-Year outcomes with Anti\u2013Vascular endothelial growth factor treatment of neovascular Age-Related macular degeneration: the comparison of Age-Related macular degeneration treatments trials. Ophthalmology. 2016;123(8):1751\u201361. https:\/\/doi.org\/10.1016\/J.OPHTHA.2016.03.045.","journal-title":"Ophthalmology"},{"key":"695_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2016.227","author":"U Schmidt-Erfurth","year":"2017","unstructured":"Schmidt-Erfurth U, Klimscha S, Waldstein SM, Bogunovi\u0107abstract H. A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration. Published Online. 2017. https:\/\/doi.org\/10.1038\/eye.2016.227.","journal-title":"Published Online"},{"issue":"7","key":"695_CR6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41433-021-01646-3","volume":"36","author":"R Chopra","year":"2022","unstructured":"Chopra R, Preston GC, Keenan TDL, et al. Intravitreal injections: past trends and future projections within a UK tertiary hospital. Eye. 2022;36(7):1373\u20138. https:\/\/doi.org\/10.1038\/s41433-021-01646-3.","journal-title":"Eye"},{"key":"695_CR7","doi-asserted-by":"publisher","first-page":"eGS6616","DOI":"10.31744\/einstein_journal\/2021GS6616","volume":"19","author":"AN Ferraz","year":"2021","unstructured":"Ferraz AN, Lemos R, da Malerbi S, Brant FK, Fernandes R. Trends in treatment of retinal disorders in the Brazilian public health system over a 10-year period. Einstein (Sao Paulo). 2021;19:eGS6616. https:\/\/doi.org\/10.31744\/einstein_journal\/2021GS6616.","journal-title":"Einstein (Sao Paulo)"},{"issue":"4","key":"695_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","volume":"128","author":"GJ Jaffe","year":"2021","unstructured":"Jaffe GJ, Westby K, Csaky KG, et al. C5 inhibitor Avacincaptad Pegol for geographic atrophy due to Age-Related macular degeneration: A randomized pivotal phase 2\/3 trial. Ophthalmology. 2021;128(4):576\u201386. https:\/\/doi.org\/10.1016\/j.ophtha.2020.08.027.","journal-title":"Ophthalmology"},{"issue":"2","key":"695_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","volume":"127","author":"DS Liao","year":"2020","unstructured":"Liao DS, Grossi FV, El Mehdi D, et al. Complement C3 inhibitor Pegcetacoplan for geographic atrophy secondary to Age-Related macular degeneration: A randomized phase 2 trial. Ophthalmology. 2020;127(2):186\u201395. https:\/\/doi.org\/10.1016\/j.ophtha.2019.07.011.","journal-title":"Ophthalmology"},{"issue":"9779","key":"695_CR10","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(11)60054-8","volume":"377","author":"J Paim","year":"2011","unstructured":"Paim J, Travassos C, Almeida C, Bahia L, MacInko J. The Brazilian health system: history, advances, and challenges. Lancet. 2011;377(9779):1778\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(11)60054-8.","journal-title":"Lancet"},{"issue":"1","key":"695_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-021-02181-1","volume":"21","author":"L Touma-Falci","year":"2021","unstructured":"Touma-Falci L, Moreira-Neto CA, Taleb AC, et al. Age-related macular degeneration and resource utilization in the Brazilian public healthcare system: a real-world retrospective study. BMC Ophthalmol. 2021;21(1):1\u201311. https:\/\/doi.org\/10.1186\/s12886-021-02181-1.","journal-title":"BMC Ophthalmol"},{"key":"695_CR12","unstructured":"CBO (Conselho Brasileiro de Oftalmologia). Densidade de oftalmologistas. observatoriocbo. Published 2021. Accessed February 1. 2024. https:\/\/observatoriocbo.com.br\/"},{"key":"695_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ajo.2017.09.027","volume":"185","author":"MA Windsor","year":"2018","unstructured":"Windsor MA, Sun SJJ, Frick KD, Swanson EA, Rosenfeld PJ, Huang D. Estimating public and patient savings from basic Research\u2014A study of optical coherence tomography in managing antiangiogenic therapy. Am J Ophthalmol. 2018;185:115\u201322. https:\/\/doi.org\/10.1016\/j.ajo.2017.09.027.","journal-title":"Am J Ophthalmol"},{"key":"695_CR14","doi-asserted-by":"publisher","unstructured":"Schmidt-Erfurth U, Sadeghipour A, Gerendas BS, Waldstein SM, Bogunovi\u0107 H. Artificial intelligence in retina. Prog Retin Eye Res. 2018;67. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.07.004.","DOI":"10.1016\/j.preteyeres.2018.07.004"},{"issue":"7","key":"695_CR15","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/s41433-022-02154-8","volume":"37","author":"LM Coulibaly","year":"2023","unstructured":"Coulibaly LM, Sacu S, Fuchs P, et al. Personalized treatment supported by automated quantitative fluid analysis in active neovascular age-related macular degeneration (nAMD)\u2014a phase III, prospective, multicentre, randomized study: design and methods. Eye. 2023;37(7):1464\u20139. https:\/\/doi.org\/10.1038\/s41433-022-02154-8.","journal-title":"Eye"},{"key":"695_CR16","doi-asserted-by":"publisher","unstructured":"Chakravarthy U, Havilio M, Syntosi A, et al. Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD. Eye Published Online January. 2021;7. https:\/\/doi.org\/10.1038\/s41433-020-01354-4.","DOI":"10.1038\/s41433-020-01354-4"},{"issue":"11","key":"695_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.oret.2022.05.030","volume":"6","author":"S Riedl","year":"2022","unstructured":"Riedl S, Vogl WD, Mai J, et al. The effect of Pegcetacoplan treatment on photoreceptor maintenance in geographic atrophy monitored by artificial Intelligence\u2013Based OCT analysis. Ophthalmol Retin. 2022;6(11):1009\u201318. https:\/\/doi.org\/10.1016\/j.oret.2022.05.030.","journal-title":"Ophthalmol Retin"},{"issue":"4","key":"695_CR18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/ajhb.10174","volume":"15","author":"A Merriwether","year":"2003","unstructured":"Merriwether A. The evolution and genetics of Latin American populations. Am J Hum Biol. 2003;15(4):595\u20136. https:\/\/doi.org\/10.1002\/ajhb.10174.","journal-title":"Am J Hum Biol"},{"issue":"August","key":"695_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2022.958469","volume":"9","author":"H Bogunovi\u0107","year":"2022","unstructured":"Bogunovi\u0107 H, Mares V, Reiter GS, Schmidt-Erfurth U. Predicting treat-and-extend outcomes and treatment intervals in neovascular age-related macular degeneration from retinal optical coherence tomography using artificial intelligence. Front Med. 2022;9(August):1\u201312. https:\/\/doi.org\/10.3389\/fmed.2022.958469.","journal-title":"Front Med"},{"key":"695_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2023.10.017","author":"GS Reiter","year":"2023","unstructured":"Reiter GS, Mares V, Leingang O, et al. Long-term effect of fluid volumes during the maintenance phase in neovascular age-related macular degeneration in the real world: results from fight retinal blindness! Can J Ophthalmol. 2023. https:\/\/doi.org\/10.1016\/j.jcjo.2023.10.017. Published online.","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"695_CR21","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/s41433-022-02077-4","volume":"37","author":"U Schmidt-Erfurth","year":"2023","unstructured":"Schmidt-Erfurth U, Mulyukov Z, Gerendas BS, et al. Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis. Eye. 2023;37(6):1160\u20139. https:\/\/doi.org\/10.1038\/s41433-022-02077-4.","journal-title":"Eye"},{"key":"695_CR22","doi-asserted-by":"publisher","unstructured":"Spaide RF, Jaffe GJ, Sarraf D, et al. Consensus nomenclature for reporting neovascular Age-Related macular degeneration data: consensus on neovascular Age-Related macular degeneration nomenclature study group. Ophthalmology. 2020;127(5). https:\/\/doi.org\/10.1016\/j.ophtha.2019.11.004.","DOI":"10.1016\/j.ophtha.2019.11.004"},{"key":"695_CR23","doi-asserted-by":"publisher","unstructured":"Schmidt-Erfurth U, Vogl WD, Jampol LM, Bogunovi\u0107 H. Application of automated quantification of fluid volumes to Anti\u2013VEGF therapy of neovascular Age-Related macular degeneration. Ophthalmology. 2020;127(9). https:\/\/doi.org\/10.1016\/j.ophtha.2020.03.010.","DOI":"10.1016\/j.ophtha.2020.03.010"},{"issue":"4","key":"695_CR24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ophtha.2017.10.031","volume":"125","author":"T Schlegl","year":"2018","unstructured":"Schlegl T, Waldstein SM, Bogunovic H, et al. Fully automated detection and quantification of macular fluid in OCT using deep learning. Ophthalmology. 2018;125(4):549\u201358. https:\/\/doi.org\/10.1016\/j.ophtha.2017.10.031.","journal-title":"Ophthalmology"},{"key":"695_CR25","doi-asserted-by":"crossref","unstructured":"Mares V, Reiter GS, Gumpinger M, Leigang O, Bogunovic H, Barthelmes D, Nehemy MB, Schmidt-Erfurth U. in (press). Correlation of retinal fluid and photoreceptor and RPE loss in neovascular AMD by automated quantification, a realworld FRB! analysis. Acta Ophthalmol. Published online 2024.","DOI":"10.1111\/aos.16799"},{"issue":"4","key":"695_CR26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.oret.2022.11.002","volume":"7","author":"G Staurenghi","year":"2023","unstructured":"Staurenghi G, Cozzi M, Sadda S, Hill L, Gune S. Characteristics that correlate with macular atrophy in Ranibizumab-Treated patients with neovascular Age-Related macular degeneration. Ophthalmol Retin. 2023;7(4):300\u20136. https:\/\/doi.org\/10.1016\/j.oret.2022.11.002.","journal-title":"Ophthalmol Retin"},{"key":"695_CR27","doi-asserted-by":"publisher","unstructured":"Mares V, Schmidt UM, Leingang O, et al. Approved AI-based fluid monitoring to identify morphological and functional treatment outcomes in related macular degeneration in real-world routine (FRB!). Published Online. 2023;1\u20137. https:\/\/doi.org\/10.1136\/bjo-2022-323014.","DOI":"10.1136\/bjo-2022-323014"},{"issue":"1","key":"695_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12910-021-00577-8","volume":"22","author":"K Murphy","year":"2021","unstructured":"Murphy K, Di Ruggiero E, Upshur R, et al. Artificial intelligence for good health: a scoping review of the ethics literature. BMC Med Ethics. 2021;22(1):1\u201317. https:\/\/doi.org\/10.1186\/s12910-021-00577-8.","journal-title":"BMC Med Ethics"},{"issue":"9","key":"695_CR29","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","volume":"24","author":"J De Fauw","year":"2018","unstructured":"De Fauw J, Ledsam JR, Romera-Paredes B, et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat Med. 2018;24(9):1342\u201350. https:\/\/doi.org\/10.1038\/s41591-018-0107-6.","journal-title":"Nat Med"},{"key":"695_CR30","doi-asserted-by":"publisher","unstructured":"Schmidt-Erfurth U, Reiter GS, Riedl S, et al. AI-based monitoring of retinal fluid in disease activity and under therapy. Prog Retin Eye Res. 2022;86. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100972.","DOI":"10.1016\/j.preteyeres.2021.100972"},{"key":"695_CR31","unstructured":"Brazilian Institute of Geography and Statistics. Resident population per location. Accessed March 18. 2024. https:\/\/censo2022.ibge.gov.br\/panorama\/indicadores.html?localidade=31"},{"key":"695_CR32","unstructured":"Brazilian Institute of Geography and Statistics. Population by color or ethnicity. Published 2022. Accessed March 18. 2024. https:\/\/censo2022.ibge.gov.br\/apps\/pgi\/#\/mapa\/"},{"issue":"1","key":"695_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40942-024-00549-1","volume":"10","author":"V Mares","year":"2024","unstructured":"Mares V, Nehemy MB, Bogunovic H, Frank S, Reiter GS, Schmidt-Erfurth U. AI-based support for optical coherence tomography in age-related macular degeneration. Int J Retin Vitr. 2024;10(1):1\u201311. https:\/\/doi.org\/10.1186\/s40942-024-00549-1.","journal-title":"Int J Retin Vitr"},{"issue":"10","key":"695_CR34","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1167\/iovs.16-20201","volume":"58","author":"S Klimscha","year":"2017","unstructured":"Klimscha S, Waldstein SM, Schlegl T, et al. Spatial correspondence between intraretinal fluid, subretinal fluid, and pigment epithelial detachment in neovascular age-related macular degeneration. Investig Ophthalmol Vis Sci. 2017;58(10):4039\u201348. https:\/\/doi.org\/10.1167\/iovs.16-20201.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"695_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/J.OPHTHA.2018.08.035","volume":"126","author":"GJ Jaffe","year":"2019","unstructured":"Jaffe GJ, Ying GS, Toth CA, et al. Macular morphology and visual acuity in year five of the comparison of Age-related macular degeneration treatments trials. Ophthalmology. 2019;126(2):252\u201360. https:\/\/doi.org\/10.1016\/J.OPHTHA.2018.08.035.","journal-title":"Ophthalmology"},{"issue":"4","key":"695_CR36","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ophtha.2015.12.002","volume":"123","author":"S Sharma","year":"2016","unstructured":"Sharma S, Toth CA, Daniel E, et al. Macular morphology and visual acuity in the second year of the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2016;123(4):865\u201375. https:\/\/doi.org\/10.1016\/j.ophtha.2015.12.002.","journal-title":"Ophthalmology"},{"issue":"5","key":"695_CR37","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/J.OPHTHA.2018.11.025","volume":"126","author":"RH Guymer","year":"2019","unstructured":"Guymer RH, Markey CM, McAllister IL, et al. Tolerating subretinal fluid in neovascular Age-Related macular degeneration treated with Ranibizumab using a Treat-and-Extend regimen: FLUID study 24-Month results. Ophthalmology. 2019;126(5):723\u201334. https:\/\/doi.org\/10.1016\/J.OPHTHA.2018.11.025.","journal-title":"Ophthalmology"},{"issue":"11","key":"695_CR38","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1097\/IAE.0000000000003180","volume":"41","author":"C Grechenig","year":"2021","unstructured":"Grechenig C, Reiter GS, Riedl S, IMPACT OF RESIDUAL SUBRETINAL FLUID VOLUMES ON TREATMENT OUTCOMES IN A SUBRETINAL FLUID\u2013TOLERANT TREAT-AND-EXTEND REGIMEN, et al. Retina. 2021;41(11):2221\u20138. https:\/\/doi.org\/10.1097\/IAE.0000000000003180.","journal-title":"Retina"},{"issue":"11","key":"695_CR39","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1097\/IAE.0000000000002717","volume":"40","author":"S Riedl","year":"2020","unstructured":"Riedl S, Cooney L, Grechenig C, TOPOGRAPHIC ANALYSIS OF PHOTORECEPTOR LOSS CORRELATED WITH DISEASE MORPHOLOGY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION, et al. Retina. 2020;40(11):2148\u201357. https:\/\/doi.org\/10.1097\/IAE.0000000000002717.","journal-title":"Retina"},{"key":"695_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ajo.2019.10.007","volume":"210","author":"M Gillies","year":"2020","unstructured":"Gillies M, Arnold J, Bhandari S, et al. Ten-Year treatment outcomes of neovascular Age-Related macular degeneration from two regions. Am J Ophthalmol. 2020;210:116\u201324. https:\/\/doi.org\/10.1016\/j.ajo.2019.10.007.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"695_CR41","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/ceo.13742","volume":"48","author":"B Wolff","year":"2020","unstructured":"Wolff B, Macioce V, Vasseur V, et al. Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: A single-centre French study. Clin Exp Ophthalmol. 2020;48(5):636\u201343. https:\/\/doi.org\/10.1111\/ceo.13742.","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"695_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-03716-8","volume":"12","author":"PK Roberts","year":"2022","unstructured":"Roberts PK, Schranz M, Motschi A, et al. Baseline predictors for subretinal fibrosis in neovascular age-related macular degeneration. Sci Rep. 2022;12(1):1\u201310. https:\/\/doi.org\/10.1038\/s41598-021-03716-8.","journal-title":"Sci Rep"},{"key":"695_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/25158414221083363","volume":"14","author":"GS Reiter","year":"2022","unstructured":"Reiter GS, Schmidt-Erfurth U. Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy. Ther Adv Ophthalmol. 2022;14:1\u201311. https:\/\/doi.org\/10.1177\/25158414221083363.","journal-title":"Ther Adv Ophthalmol"},{"issue":"11","key":"695_CR44","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1097\/IAE.0000000000002195","volume":"38","author":"AM Khanani","year":"2018","unstructured":"Khanani AM, Eichenbaum D, Schlottmann PG, Tuomi L, Sarraf D. Optimal management of pigment epithelial detachments in eyes with neovascular age-related macular degeneration. Retina. 2018;38(11):2103\u201317. https:\/\/doi.org\/10.1097\/IAE.0000000000002195.","journal-title":"Retina"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00695-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T17:08:13Z","timestamp":1751821693000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00695-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["695"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00695-0","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,6]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with the declaration of Helsinki and had approval from the institutional review board (CAAE 58850622.4.0000.5149). Patients\u2019 informed consent was exempted because of the retrospective nature of this study using fully anonymized retinal images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}